NCI at ASCO 2018Monday, June 4Today is the fourth day of the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting and we hope you are having a good conference. Today is also the last day of NCI's "Meet the Experts" sessions - so make sure to stop by our booth to hear what's happening across NCI (#5041). You can also attend the NCI-featured sessions below. For more information about NCI activities at ASCO, visit the NCI at ASCO 2018 webpage. | |||
NCI Speakers and Sessions at ASCO (Monday)
Immunoepigenetics: Therapeutic Implications of Cancer Immunoediting
David Schrump, M.D.
1:15 PM - 1:35 PM In this presentation by Dr. Schrump, learn about the role of epigenetic priming, and its potential impact to improve outcomes when using immunotherapy to treat patients with cancer.
Results of PROSPECT
James Gulley, M.D., Ph.D., FACP
5:00 PM - 5:12 PM At the “Genitourinary (Prostate) Cancer” oral abstract session, Dr. Gully will discuss results from the PROSPECT trial, (a randomized phase 3 trial of PROSTVAC-V/F (PRO) in men with asymptomatic or minimally symptomatic metastatic, castration-resistant prostate cancer). Activities at the NCI Exhibit Booth (#5041)
|
Cancer Nanotechnology
Hace 10 horas
No hay comentarios:
Publicar un comentario